C-reactive Protein Versus Erythrocyte Sedimentation Rate in Estimating the 28-joint Disease Activity Score

REFERENCES

1. 1.↵
   1. Prevoo ML,
   2. van ’t Hof MA,
   3. Kuper HH,
   4. van Leeuwen MA,
   5. van de Putte LB,
   6. van Riel PL

   . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Van der Heijde DM,
   2. van ’t Hof MA,
   3. van Riel PL,
   4. Theunisse LA,
   5. Lubberts EW,
   6. van Leeuwen MA,
   7. et al.

   Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916–20.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Van Leeuwen MA,
   2. van Rijswijk MH

   . Acute phase proteins in the monitoring of inflammatory disorders. Baillières Clin Rheumatol 1994;8:531–52.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Madsen OR

   . Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice? Clin Rheumatol 2011; 30:1577–82.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Wells G,
   2. Becker J-C,
   3. Teng J,
   4. Dougados M,
   5. Schiff M,
   6. Smolen J,
   7. et al.

   Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009;68:954–60.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Inoue E,
   2. Yamanaka H,
   3. Hara M,
   4. Tomatsu T,
   5. Kamatani N

   . Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis 2007;66:407–9.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Matsui T,
   2. Kuga Y,
   3. Kaneko A,
   4. Nishino J,
   5. Eto Y,
   6. Chiba N,
   7. et al.

   Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 2007;66:1221–6.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Castrejón I,
   2. Ortiz AM,
   3. García-Vicuña R,
   4. Lopez-Bote JP,
   5. Humbría A,
   6. Carmona L,
   7. et al.

   Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol 2008;26:769–75.

   OpenUrlPubMed
9. 9.↵
   1. Hensor EM,
   2. Emery P,
   3. Bingham SJ,
   4. Conaghan PG; and
   5. YEAR Consortium

   . Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): can they be reduced? Rheumatology 2010;49:1521–9.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Tamhane A,
    2. Redden DT,
    3. McGwin G Jr.,
    4. Brown EE,
    5. Westfall AO,
    6. Reynolds RJ IV.,
    7. et al.

    Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis. J Rheumatol 2013;40:1812–22.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Plant D,
    2. Ibrahim I,
    3. Lunt M,
    4. Eyre S,
    5. Flynn E,
    6. Hyrich KL,
    7. et al.

    Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Arthritis Res Ther 2012;14:R214.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Klarenbeek NB,
    2. Koevoets R,
    3. van der Heijde DM,
    4. Gerards AH,
    5. Ten Wolde S,
    6. Kerstens PJ,
    7. et al.

    Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. Ann Rheum Dis 2011;70:1815–21.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Gaujoux-Viala C,
    2. Mouterde G,
    3. Baillet A,
    4. Claudepierre P,
    5. Fautrel B,
    6. Le Loët X,
    7. et al.

    Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Joint Bone Spine 2012;79:149–55.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Smolen JS,
    2. Breedveld FC,
    3. Schiff MH,
    4. Kalden JR,
    5. Emery P,
    6. Eberl G,
    7. et al.

    A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003;42:244–57.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Aletaha D,
    2. Nell VP,
    3. Stamm T,
    4. Uffmann M,
    5. Pflugbeil S,
    6. Machold K,
    7. et al.

    Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7:796–806.

    OpenUrlCrossRef